Lipid Targets for Patients With Diabetes
|
ADA |
AACE |
AADE |
IDF/WHO |
LDL |
<100 mg/dL |
<100 mg/dL |
<100 mg/dL |
<100 mg/dL |
HDL |
>40 mg/dL (men)
>50 mg/dL (women) |
>45 mg/dL |
>40 mg/dL (men)
>50 mg/dL (women) |
>40 mg/dL (men)
>46 mg/dL (women) |
Triglycerides |
<150 mg/dL |
<150 mg/dL |
<150 mg/dL |
<150 mg/dL |
NCEP/ATP III Proposed Cholesterol Goal Modifications
Risk Category* |
LDL Goal (mg/dL) |
High risk: CHD and CHD risk equivalents (diabetes) |
<100
(optional goal <70)† |
Moderately high risk: multiple (2+) risk factors (10-year risk 10% to 20 %) |
<130
(optional goal <100)‡ |
Moderate risk: 2+ risk factors (10-year risk <10%) |
<130 |
Lower risk: zero to one risk factor |
<160 |
*Risk factors include cigarette smoking, hypertension (BP ≥140/90 mm Hg or on antihypertensive medication), HDL cholesterol <40 mg/dL, family history of premature CHD (male <55 years, females <65 years) and age (males >45 years, females >55 years).
†LDL goal of <70 mg/dL is a reasonable therapeutic option in patients at very high risk for CVD (diabetes plus CVD). Recommendation based on new clinical trial evidence.
‡LDL goal of <100 mg/dL is a reasonable therapeutic option in patients at moderately high risk for CVD (2+ risk factors and 10-year risk 10% to 20%). Recommendation based on new clinical trial evidence.
|
